本页面由Tiger Trade Technology Pte. Ltd.提供服务

Seres Therapeutics, Inc.

8.83
-0.0100-0.11%
盘后8.830.00000.00%19:20 EDT
成交量:5.84万
成交额:51.33万
市值:8,464.70万
市盈率:13.80
高:8.93
开:8.93
低:8.58
收:8.84
52周最高:29.98
52周最低:6.53
股本:958.63万
流通股本:729.26万
量比:1.52
换手率:0.80%
股息:- -
股息率:- -
每股收益(TTM):0.6400
每股收益(LYR):0.0175
净资产收益率:19.64%
总资产收益率:-42.25%
市净率:1.91
市盈率(LYR):504.48

数据加载中...

2020/09/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/09/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/08/19

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/08/17

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/08/14

重要事件披露

8-K - Current report
2020/08/13

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/08/13

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/08/10

重要事件披露

8-K - Current report
2020/07/28

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/06/22

重要事件披露

8-K - Current report
2020/05/07

季度报告

Quarterly report [Sections 13 or 15(d)]
2020/05/07

重要事件披露

Current report, items 2.02 and 9.01
2020/03/23

重要事件披露

Current report, item 5.02
2020/03/18

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2020/03/16

SEC问询函

CORRESP [Cover] - Correspondence
2020/03/02

员工持股计划

Securities to be offered to employees in employee benefit plans
2020/03/02

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/02

重要事件披露

Current report, items 2.02 and 9.01
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals